The Neuroscience of Spinal Cord Injury

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Front Matter for Volume 1 - p. iii 5. Diagnosis and Treatment of Spinal Cord Injury: The Neuroscience of Spinal Cord Injury - p. iii 6. Copyright for Volume 1 - p. iv 7. Dedication for Volume 1 - p. v 8. Contributors for Volume 1 - p. xxi 9. Preface for Volume 1 - p. xxvii 10. Front Matter for Volume 2 - p. xxviii 11. Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury: The Neuroscience of Spinal Cord Injury - p. xxviii 12. Copyright for Volume 2 - p. xxviii 13. Dedication for Volume 2 - p. xxviii 14. Contributors for Volume 2 - p. xxviii 15. Preface for Volume 2 - p. xxviii 16. Volume 1: Diagnosis and Treatment of Spinal Cord Injury: The Neuroscience of Spinal Cord Injury - p. xxviii 17. Section A: Setting the scene: Introductory chapters - p. xxviii 18. Chapter 1: Traumatic spinal cord injury and outcomes in low-resource settings - p. vol1-3 19. Chapter 2: Biomechanics and patterns of spine injuries associated with spinal cord injury - p. vol1-15 20. Chapter 3: Body, action, and space representations in people affected by spinal cord injuries - p. vol1-27 21. Chapter 4: Methods for treating pain and painful syndromes in spinal cord injury: Medications, therapies, interventions, and neuromodulation - p. vol1-41 22. Section B: Clinical features of spinal injury - p. vol1-52 23. Chapter 5: Factors contributing to pressure injuries in traumatic spinal cord injury - p. vol1-55 24. Chapter 6: Venous thromboembolism in spinal cord injury—Prophylaxis, diagnosis and treatment - p. vol1-69 25. Chapter 7: Osteoporosis-related fractures: What they are and how they occur following spinal cord injury - p. vol1-83 26. Chapter 8: Understanding the effects of prolonged cervical spinal cord compression on the brain. Current knowledge and future challenges - p. vol1-95 27. Chapter 9: Spasticity in spinal cord injury - p. vol1-107 28. Chapter 10: Fall circumstances, consequences, assessments, and interventions to manage fall risk among individuals living with spinal cord injury - p. vol1-117 29. Chapter 11: Infections and spinal cord injury: Covid-19 and beyond - p. vol1-131 30. Chapter 12: Sleep problems in spinal cord injury - p. vol1-147 31. Section C: Diagnosis and evaluation - p. vol1-157 32. Chapter 13: Biomarkers in spinal cord injury: A highlight on prognostic insights - p. vol1-161 33. Chapter 14: Quality of life tools for spinal cord–injured people - p. vol1-173 34. Chapter 15: S100b in spinal cord injury - p. vol1-191 35. Chapter 16: Assessment of postural control after spinal cord injury or disease: A narrative review - p. vol1-199 36. Section D: Treatments: Experimental and clinical - p. vol1-213 37. Chapter 17: Surgical management of acute spinal cord injury in emergency setting - p. vol1-217 38. Chapter 18: Spinal cord epidural stimulation for autonomic nervous system control: A focus on improving bladder, bowel, and cardiovascular function - p. vol1-229 39. Chapter 19: Treating spinal cord injury with implanted spinal cord stimulators - p. vol1-245 40. Chapter 20: Bowel dysfunction in spinal cord injury - p. vol1-259 41. Chapter 21: Management of neurogenic lower urinary tract dysfunction due to spinal cord injury - p. vol1-273 42. Chapter 22: Bed support surfaces for preventing pressure injuries after spinal cord injury - p. vol1-287 43. Chapter 23: Nerve and tendon transfers in tetraplegia: A new narrative - p. vol1-299 44. Chapter 24: GEMINI-supported spinal cord transplantation for the treatment of chronic spinal paralysis: Overview and initial clinical translation - p. vol1-313 45. Chapter 25: Chondroitinase ABC I as a novel candidate for reducing damage in spinal cord injury - p. vol1-325 46. Chapter 26: Phenol neurolysis for spasticity management in people with spinal cord injury - p. vol1-337 47. Chapter 27: Anti-repulsive guidance molecule: An antibody treatment in spinal cord injury - p. vol1-347 48. Chapter 28: Mitochondrial biogenesis for the treatment of spinal cord injury - p. vol1-359 49. Chapter 29: Exploring the exogenous and endogenous effects of melatonin on spinal cord injury - p. vol1-373 50. Chapter 30: High-intensity interval training in individuals with spinal cord injury - p. vol1-385 51. Chapter 31: Stem cells and chronic spinal cord injury: Overview - p. vol1-397 52. Chapter 32: Viral vector gene therapy approaches for regeneration and repair in spinal cord injury - p. vol1-411 53. Chapter 33: Curcumin usage for inflammation and spinal cord injury - p. vol1-425 54. Chapter 34: Use of (−)-epigallocatechin-3-gallate on spinal cord injury - p. vol1-437 55. Chapter 35: Vitamin D and spinal cord injury - p. vol1-453 56. Chapter 36: Corticospinal tract regeneration after spinal cord injury: Implications for treatment and recovery - p. vol1-461 57. Chapter 37: Trophic factors in patients with spinal cord injury - p. vol1-475 58. Section E: Rehabilitation in spinal injury - p. vol1-487 59. Chapter 38: Spinal cord injury: Multiple family group (MFG) education and support - p. vol1-491 60. Chapter 39: Spinal cord injury rehabilitation: Linking service delivery and community integration - p. vol1-501 61. Chapter 40: Rehabilitation in spinal cord injury: Exercise and testing for cardiorespiratory endurance and musculoskeletal fitness - p. vol1-513 62. Chapter 41: Community-based activity-based therapy for spinal cord injuries rehabilitation - p. vol1-525 63. Chapter 42: Mobile health apps and self-management for spinal cord injury rehabilitation - p. vol1-539 64. Chapter 43: Biomaterials, spinal cord injury, and rehabilitation: A new narrative - p. vol1-549 65. Chapter 44: Support in spinal cord injury: A focus on robotics - p. vol1-563 66. Section F: Resources - p. vol1-573 67. Chapter 45: Recommended resources and sites for the neuroscience of spinal cord injury - p. vol1-577 68. Volume 2: Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury: The Neuroscience of Spinal Cord Injury - p. vol1-586 69. Section A: Setting the scene and introductory chapters - p. vol1-586 70. Chapter 1: Causes of spinal injury: Motor vehicle accidents and beyond - p. vol2-3 71. Chapter 2: Magnetic resonance imaging (MRI) findings in spinal cord injury during acute and chronic phases - p. vol2-11 72. Chapter 3: Exercise programs and spinal cord injury (SCI): Linking the clinical, physiological, and psychological consequences of SCI - p. vol2-23 73. Chapter 4: Use of anodal transcranial direct current stimulation: Features, facets, and applications to incomplete spinal cord injury - p. vol2-35 74. Chapter 5: Neuromodulation and restoration of motor responses after severe spinal cord injury - p. vol2-51 75. Chapter 6: Rehabilitation and wheelchair users after spinal cord injury: An overview - p. vol2-65 76. Section B: Cellular and molecular aspects of spinal injury - p. vol2-77 77. Chapter 7: Gene expression and bone loss following spinal cord injury - p. vol2-81 78. Chapter 8: Sperm DNA fragmentation and its relevance to men with spinal cord injury - p. vol2-93 79. Chapter 9: Beneficial and detrimental effects of cytokines after spinal cord injury - p. vol2-105 80. Chapter 10: Neurovascular pathology following traumatic spinal cord injury - p. vol2-119 81. Chapter 11: Protein degradome in spinal cord injury - p. vol2-133 82. Chapter 12: Proteomics of pressure ulcers in spinal cord injury - p. vol2-143 83. Chapter 13: Innate immune responses of glia and inflammatory cells in spinal cord injury - p. vol2-153 84. Chapter 14: The role of oxidative stress in spinal cord injury animal models: A focus on nuclear factor erythroid-2 related factor 2 - p. vol2-165 85. Chapter 15: Novel agent ONO-2506 suppresses astrocytic activation and attenuates post-spinal cord injury pain - p. vol2-177 86. Chapter 16: Neural tissue loss after spinal cord injury - p. vol2-187 87. Chapter 17: Remodeling mitochondrial transport and cellular energetics in axonal regeneration and spinal cord injury - p. vol2-199 88. Chapter 18: Neurotrophins and their role in axonal outgrowth following spinal cord injury - p. vol2-215 89. Chapter 19: The neuroscience of transient receptor potential vanilloid type 4 (TRPV4) and spinal cord injury - p. vol2-229 90. Chapter 20: Autoantibodies in spinal cord injury - p. vol2-239 91. Chapter 21: Calpain role in the pathophysiology of spasticity after spinal cord injury - p. vol2-249 92. Chapter 22: Targeting mTOR signaling to promote autophagy for functional recovery after spinal cord injury - p. vol2-263 93. Chapter 23: Tertiary damage: Hippocampal and brain changes after spinal cord injury - p. vol2-275 94. Section C: Physiological and metabolic effects - p. vol2-285 95. Chapter 24: Hormonal events and spinal cord injury: A focus on vasopressin and natriuretic peptide - p. vol2-289 96. Chapter 25: Linking sensorimotor plasticity, the motor cortex, and spinal cord injury - p. vol2-301 97. Chapter 26: Bone loss at the knee after spinal cord injury: Radiographic imaging, fracture risk, and treatment - p. vol2-315 98. Chapter 27: Functional and morphological reorganization of the brain following spinal cord injury: Insights from MRI - p. vol2-327 99. Chapter 28: Cardiometabolic changes and upper exercise as an augmentative strategy in spinal cord injury - p. vol2-339 100. Chapter 29: Electrophysiological outcome measures in spinal cord injury: A new narrative - p. vol2-351 101. Chapter 30: Features and physiology of spinal stretch reflexes in people with chronic spinal cord injury - p. vol2-365 102. Chapter 31: Metabolic syndrome in spinal cord injury: Impact on health - p. vol2-377 103. Chapter 32: Body composition and spinal cord injury - p. vol2-389 104. Chapter 33: Energy requirements and spinal cord injury - p. vol2-405 105. Chapter 34: Virtual walking and spinal cord injury neuropathic pain - p. vol2-413 106. Chapter 35: Cervical spinal cord injury and thermoregulatory processes: A new narrative - p. vol2-425 107. Chapter 36: Spinal cord injury and the gut microbiota - p. vol2-435 108. Section D: Behavioral and psychological effects - p. vol2-444 109. Chapter 37: Risk factors and predictors of depression after spinal cord injury: Emphasis on the inflammatory process - p. vol2-447 110. Chapter 38: Spirituality, hope, and resilience in the recovery and adaptation process following spinal cord injury - p. vol2-459 111. Chapter 39: Wellness intervention for persons with spinal cord injury - p. vol2-471 112. Chapter 40: Sexual life in individuals with spinal cord injury and management - p. vol2-483 113. Chapter 41: Depressive symptoms in rehabilitation post-spinal cord injury - p. vol2-497 114. Chapter 42: Self-harm behaviors in patients with spinal cord injuries: From non-adherence to suicide - p. vol2-509 115. Index for volume 1 - p. vol1-587 116. Index for volume 2 - p. vol2-521